James T. Boyle Jr., EVP, CEO of Lab Corporate Diagnostics at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 8,110 shares at $103.02 ($835K) on 2016-02-16, disclosed to the SEC on 2016-02-18.
Seasonal sale ($835k) by EVP, CEO of Lab Corporate Diagnostics — this insider has traded LH in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.02 | 1,895 | $195K | 23.4% |
| 2 | $103.02 | 1,895 | $195K | 23.4% |
| 3 | $103.02 | 2,160 | $223K | 26.6% |
| 4 | $103.02 | 2,160 | $223K | 26.6% |
| Total | $103.02 avg | 8,110 | $835K | 100% |
| Filing → |
| LH | SELL | 2016-02-16 | $276K | — | Filing → |
| LH | SELL | 2015-04-27 | $176K | — | Filing → |
| LH | SELL | 2015-03-04 | $153K | — | Filing → |